BioLife Solutions, Inc.
BLFS
$20.67
-$1.78-7.91%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -3.42M | 30.57M | 28.33M | 26.78M | -6.14M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -3.42M | 30.57M | 28.33M | 26.78M | -6.14M |
| Cost of Revenue | -11.70M | 14.28M | 13.44M | 12.57M | -15.07M |
| Gross Profit | 8.27M | 16.30M | 14.89M | 14.21M | 8.93M |
| SG&A Expenses | 5.80M | 14.89M | 14.40M | 15.07M | 5.67M |
| Depreciation & Amortization | 3.00K | 910.00K | 910.00K | 914.00K | -615.00K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -4.81M | 32.13M | 31.12M | 30.94M | -8.71M |
| Operating Income | 1.39M | -1.56M | -2.80M | -4.16M | 2.57M |
| Income Before Tax | 1.54M | -1.73M | -7.15M | -4.09M | 11.36M |
| Income Tax Expenses | -131.00K | -28.00K | -- | 121.00K | -233.00K |
| Earnings from Continuing Operations | 1.67M | -1.70M | -7.15M | -4.21M | 11.60M |
| Earnings from Discontinued Operations | 10.79M | -- | -13.57M | -6.01M | -26.55M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 12.46M | -1.70M | -20.72M | -10.22M | -14.96M |
| EBIT | 1.39M | -1.56M | -2.80M | -4.16M | 2.57M |
| EBITDA | 2.76M | 758.00K | -433.00K | -1.88M | 4.95M |
| EPS Basic | 0.27 | -0.04 | -0.45 | -0.23 | -0.33 |
| Normalized Basic EPS | 0.02 | -0.02 | -0.04 | -0.06 | 0.04 |
| EPS Diluted | 0.26 | -0.04 | -0.45 | -0.23 | -0.33 |
| Normalized Diluted EPS | 0.02 | -0.02 | -0.04 | -0.06 | 0.04 |
| Average Basic Shares Outstanding | 46.65M | 46.18M | 46.00M | 45.43M | 44.82M |
| Average Diluted Shares Outstanding | 48.03M | 46.18M | 46.00M | 45.43M | 44.82M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
